Company news: Lilly, Merck KGaA

Share this article:

Eli Lilly released a diabetes app Tuesday that is aimed at educating caregivers. The Lilly Glucagon Mobile App is designed for iPhones and iPads and teaches users how to inject Glucagon into type 1 diabetics as well as provides background information about how Glucagon helps patients manage diabetes. The injection is for severe hypoglycemia.

Merck KGaA's “Fit for 2018” plan calls for thinning employee ranks by 1,100 positions. The company said in a statement that the majority of the job cuts will come through attrition – voluntary resignations and early retirements – and expects that most of the jobs will be gone by the end of 2015. The company said the gradual reduction was part of an agreement between employee and company representatives, and stipulated that active pink-slipping that is part of the company's efficiency strategy will not begin until the end of 2017 at the earliest, not including possible site closures that may occur in the interim.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.